Goldline Pharmaceutical Ltd. (BSE SME)

Goldline Pharmaceutical Ltd. (BSE SME)

NSE - SMEClosed
Min. Investment
₹1,29,000
/ 3000 Shares
Check Allotment Status
Issue Price
41-43
Subscription
-
Issue Size
11.61
Lot Size
3000
Open
May 12, 2026
Close
May 14, 2026
Allotment
May 15, 2026
Listing
May 19, 2026

Grey Market Premium

Estimated listing gains (Live)

+15 (34.9%)Per Share
EST. GAINS
Updated real-time from market sources

IPO Lot Size

CategoryShares Offered%
Anchor73200027.11%
QIB54000020%
HNI39000014.44%
INDIVIDUAL90000033.33%
Market Maker1380005.11%
Total2700000100%

Goldline Pharmaceutical Listing Price

ExchangeListing PriceGain/Loss%
BSE₹59.75+₹16.75+38.95%

Goldline Pharmaceutical Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
bHNI824000103200029

Frequently Asked Questions (Goldline Pharmaceutical Ltd.)

D
Founder | India IPO Updates

DIPAK DANGODARA

I am the founder of India IPO Updates, a platform dedicated to tracking the Indian IPO market since 2024. With a background in digital research and data analysis, I built this platform to simplify IPO tracking covering issue details, live Grey Market Premium (GMP), subscription status, and allotment updates sourced from public exchange data and verified market sources.

I am not an SEBI-registered investment advisor. All GMP and market data shared here is for informational purposes only and should not be considered investment advice. Investors are advised to consult a registered financial advisor before making investment decisions.